Neurorehabilitation News

DENVER — Deterioration of memory and executive functions were associated with worsening quality of life for those with Parkinson’s disease over a 3-year period, according to a poster at the American Academy of Neurology annual meeting.

DENVER — Exposure to airborne manganese may be a significant contributing factor to risk of Parkinson’s disease, according to a poster from the American Academy of Neurology annual meeting.

Nearly all study participants believed to have a synucleinopathy had the presence of alpha-synuclein in their skin samples, according to a study presented at the American Academy of Neurology annual meeting.

The FDA has cleared an investigational new drug application for a small molecule therapeutic to treat those with Fragile X syndrome, according to the manufacturer.

DENVER —Extracorporeal membrane oxygenation therapy led to favorable survival and neurologic outcomes for patients who required neurosurgical intervention, according to a poster at the American Academy of Neurology annual meeting.

DENVER — Metagenomic next-generation sequencing may be a reliable diagnostic tool to analyze causes of highly contagious meningitis or encephalitis in a clinical setting, according to a speaker.

DENVER — Treatment with IV efgartigimod improved functionality for individuals with acetylcholine receptor-positive generalized myasthenia gravis, according to a poster from the American Academy of Neurology annual meeting.

DENVER – A machine-learning seizure burden monitoring algorithm was able to predict the level of poor functional outcomes in those with neurological conditions, according to new research.

The National Institute of Neurological Disorders and Stroke has awarded a grant to researchers at Hackensack Meridian Neuroscience Institute to study a novel approach to improving outcomes after TBI.

A European clinical stage biotech company announced dosing of the first patient in cohort 2 of its ongoing phase 1/2 GATEWAY clinical trial of lead candidate VTX-801 to treat Wilson’s disease.